Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

Novartis Pharmaceuticals · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
italynis
active secondary progressive multiple sclerosis, secondary progressive multiple sclerosis, aspms, nis, italy, mayzent, siponimod, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 874906
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.